Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

8.31 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192001
Operating Activities:
Net Income -892.869-2,106.372-1,836.642-126.723-119.857-2,106.372
Depreciation & Amortization 71.55444.42329.07613.86410.75544.423
Deferred Income Tax -0.801-14.60930.2124.12954.733-14.609
Stock Based Compensation 229.8841,930.6411,606.020.4760.7711,930.641
Change In Working Capital 29.837-37.006-61.537-26.51510.57755.024
Accounts Receivables 50.06855.024-114.094-14.228-1.84355.024
Inventory 00.164-0.626-2.736-2.2220
Accounts Payables -1.183-10.844-2.2477.0190.6640
Other Working Capital -19.048-81.3555.43-16.5713.978-55.024
Other Non Cash Items 266.895-69.275-20.947-1.061-1.642-55.024
Operating Cash Flow -295.5-252.198-253.818-135.83-44.663-145.917
Investing Activities:
Investments In Property Plant And Equipment -40.801-52.271-56.521-57.821-22.2190
Acquisitions Net -38.55226.646-12.04000
Purchases Of Investments 0-3.691-50-50.1330
Sales Maturities Of Investments 000000
Other Investing Activites -1.34-38.0780.304-9.3-2.250
Investing Cash Flow -80.693-67.394-73.257-67.121-74.6020
Financing Activities:
Debt Repayment -1.295-1.237-1.123-0.748-0.8280
Common Stock Issued -0.48799.3031,509.79691.06600
Common Stock Repurchased -0.023-0.981-24.9980-0.4080
Dividends Paid 000000
Other Financing Activities -1.434-0.7671,560.26690.318411.6210
Financing Cash Flow -3.21695.3371,534.14590.318410.3850
Other Information:
Effect Of Forex Changes On Cash -0.5880.908-0.019000
Net Change In Cash -375.151-223.3471,207.051-112.633291.12-145.917
Cash At End Of Period 948.8621,369.5811,592.928385.877498.51-145.917